Literature DB >> 31961138

Antibody Targeted PET Imaging of 64Cu-DOTA-Anti-CEA PEGylated Lipid Nanodiscs in CEA Positive Tumors.

Patty Wong1, Lin Li2, Junie Chea3, Weidong Hu2, Erasmus Poku3, Todd Ebner2, Nicole Bowles3, Jeffrey Y C Wong1, Paul J Yazaki2, Stephen Sligar4, John E Shively2.   

Abstract

Lipid nanodiscs (LNDs), comprising a phospholipid bilayer encircled by two molecules of a recombinant membrane scaffold protein, can be targeted to tumors with covalently attached antibodies (Abs) or their fragments. Antibody attachment to click chemistry based PEGylated lipids on LNDs including DOTA allowed PET imaging with the positron emitter 64Cu. Carcinoembryonic antigen (CEA) positive tumors in CEA transgenic mice were chosen as a tumor target. Fab' fragments, that otherwise are rapidly cleared by the kidney due to their small size, were retained in circulation when conjugated to LNDs. Untargeted PET imaging of 64Cu-DOTA-LNDs revealed low tumor uptake (4-5% ID/g) in the range expected for the enhanced permeability retention (EPR) effect with high liver uptake (17-21% ID/g) indicating gut clearance. Fab' targeted LNDs showed little improvement over untargeted LNDs, but intact IgG targeted LNDs gave high tumor uptake (40% ID/g) with low liver (8% ID/g), demonstrating that tumor targeting with antibody conjugated LNDs is feasible.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31961138      PMCID: PMC8818266          DOI: 10.1021/acs.bioconjchem.9b00854

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  30 in total

1.  Immunoliposomes bearing polyethyleneglycol-coupled Fab' fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo.

Authors:  K Maruyama; N Takahashi; T Tagawa; K Nagaike; M Iwatsuru
Journal:  FEBS Lett       Date:  1997-08-11       Impact factor: 4.124

Review 2.  Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic.

Authors:  Anu Puri; Kristin Loomis; Brandon Smith; Jae-Ho Lee; Amichai Yavlovich; Eliahu Heldman; Robert Blumenthal
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2009       Impact factor: 4.889

3.  A versatile bifunctional chelate for radiolabeling humanized anti-CEA antibody with In-111 and Cu-64 at either thiol or amino groups: PET imaging of CEA-positive tumors with whole antibodies.

Authors:  Lin Li; James Bading; Paul J Yazaki; Amitkumar H Ahuja; Desiree Crow; David Colcher; Lawrence E Williams; Jeffrey Y C Wong; Andrew Raubitschek; John E Shively
Journal:  Bioconjug Chem       Date:  2007-11-08       Impact factor: 4.774

4.  Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells.

Authors:  Daniela Pozzi; Valentina Colapicchioni; Giulio Caracciolo; Susy Piovesana; Anna Laura Capriotti; Sara Palchetti; Stefania De Grossi; Anna Riccioli; Heinz Amenitsch; Aldo Laganà
Journal:  Nanoscale       Date:  2014-01-27       Impact factor: 7.790

Review 5.  Membrane protein assembly into Nanodiscs.

Authors:  Timothy H Bayburt; Stephen G Sligar
Journal:  FEBS Lett       Date:  2009-10-16       Impact factor: 4.124

6.  124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice.

Authors:  Gobalakrishnan Sundaresan; Paul J Yazaki; John E Shively; Ronald D Finn; Steven M Larson; Andrew A Raubitschek; Lawrence E Williams; Arion F Chatziioannou; Sanjiv S Gambhir; Anna M Wu
Journal:  J Nucl Med       Date:  2003-12       Impact factor: 10.057

7.  Characterization of 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[Methoxy(polyethylene glycerol)-2000] and Its Complex with Doxorubicin Using Nuclear Magnetic Resonance Spectroscopy and Molecular Dynamics.

Authors:  Weidong Hu; Allen Mao; Patty Wong; Adrien Larsen; Paul J Yazaki; Jeffrey Y C Wong; John E Shively
Journal:  Bioconjug Chem       Date:  2017-06-09       Impact factor: 4.774

8.  Tracking Antibody Distribution with Near-Infrared Fluorescent Dyes: Impact of Dye Structure and Degree of Labeling on Plasma Clearance.

Authors:  Cornelius Cilliers; Ian Nessler; Nikolas Christodolu; Greg M Thurber
Journal:  Mol Pharm       Date:  2017-03-31       Impact factor: 4.939

9.  Radioimmunoimaging of liver metastases with PET using a 64Cu-labeled CEA antibody in transgenic mice.

Authors:  Stefanie Nittka; Marcel A Krueger; John E Shively; Hanne Boll; Marc A Brockmann; Fabian Doyon; Bernd J Pichler; Michael Neumaier
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240

Review 10.  Lipid nanoparticles for targeted siRNA delivery - going from bench to bedside.

Authors:  Timofei S Zatsepin; Yuri V Kotelevtsev; Victor Koteliansky
Journal:  Int J Nanomedicine       Date:  2016-07-05
View more
  4 in total

Review 1.  Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology.

Authors:  Martha Sahylí Ortega Pijeira; Herlys Viltres; Jan Kozempel; Michal Sakmár; Martin Vlk; Derya İlem-Özdemir; Meliha Ekinci; Seshasai Srinivasan; Amin Reza Rajabzadeh; Eduardo Ricci-Junior; Luciana Magalhães Rebelo Alencar; Mohammed Al Qahtani; Ralph Santos-Oliveira
Journal:  EJNMMI Radiopharm Chem       Date:  2022-04-25

2.  Single-component nanodiscs via the thermal folding of amphiphilic graft copolymers with the adjusted flexibility of the main chain.

Authors:  Tomoki Nishimura; Yusuke Hatatani; Mitsuru Ando; Yoshihiro Sasaki; Kazunari Akiyoshi
Journal:  Chem Sci       Date:  2022-04-19       Impact factor: 9.969

Review 3.  Nanodiscs: A toolkit for membrane protein science.

Authors:  Stephen G Sligar; Ilia G Denisov
Journal:  Protein Sci       Date:  2020-11-16       Impact factor: 6.993

Review 4.  Overview and Future Perspectives on Tumor-Targeted Positron Emission Tomography and Fluorescence Imaging of Pancreatic Cancer in the Era of Neoadjuvant Therapy.

Authors:  Martijn A van Dam; Floris A Vuijk; Judith A Stibbe; Ruben D Houvast; Saskia A C Luelmo; Stijn Crobach; Shirin Shahbazi Feshtali; Lioe-Fee de Geus-Oei; Bert A Bonsing; Cornelis F M Sier; Peter J K Kuppen; Rutger-Jan Swijnenburg; Albert D Windhorst; Jacobus Burggraaf; Alexander L Vahrmeijer; J Sven D Mieog
Journal:  Cancers (Basel)       Date:  2021-12-02       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.